当前位置: X-MOL 学术Bioorg. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix approach
Bioorganic & Medicinal Chemistry ( IF 3.5 ) Pub Date : 2021-08-08 , DOI: 10.1016/j.bmc.2021.116357
Rohmad Yudi Utomo 1 , Yasunobu Asawa 1 , Satoshi Okada 2 , Hyun Seung Ban 3 , Atsushi Yoshimori 4 , Jürgen Bajorath 5 , Hiroyuki Nakamura 2
Affiliation  

Amyloid β (Aβ) aggregation inhibitor activity cliff involving a curcumin structure was predicted using the SAR Matrix method on the basis of 697 known Aβ inhibitors from ChEMBL (data set 2487). Among the compounds predicted, compound B was found to possess approximately 100 times higher inhibitory activity toward Aβ aggregation than curcumin. TEM images indicate that compound B induced the shortening of Aβ fibrils and increased the generation of Aβ oligomers in a concentration dependent manner. Furthermore, compound K, in which the methyl ester of compound B was replaced by the tert-butyl ester, possessed low cytotoxicity on N2A cells and attenuated Aβ-induced cytotoxicity, indicating that compound K would have an ability for preventing neurotoxicity caused by Aβ aggregation.



中文翻译:

使用 SAR 矩阵方法开发基于姜黄素的淀粉样蛋白 β 聚集抑制剂治疗阿尔茨海默病

基于来自 ChEMBL 的 697 种已知 Aβ 抑制剂(数据集 2487),使用 SAR 矩阵方法预测了涉及姜黄素结构的淀粉样蛋白 β (Aβ) 聚集抑制剂活性悬崖。在预测的化合物中,发现化合物B对 Aβ 聚集的抑制活性比姜黄素高约 100 倍。TEM 图像表明化合物B以浓度依赖性方式诱导 Aβ 原纤维缩短并增加 Aβ 寡聚体的产生。此外,化合物K,其中化合物B的甲酯被叔丁酯取代,对N2A细胞具有低细胞毒性并减弱Aβ诱导的细胞毒性,表明化合物K 将具有预防由 Aβ 聚集引起的神经毒性的能力。

更新日期:2021-08-11
down
wechat
bug